Interferons (IFNs) are cytokines with pronounced proinflammatory properties. Here we provide evidence that IFNs play a key role also in decline of inflammation by inducing expression of tristetraprolin (TTP). TTP is an RNA-binding protein that destabilizes several AU-rich element-containing mRNAs including TNF . By promoting mRNA decay TTP significantly contributes to cytokine homeostasis. Now we report that IFNs strongly stimulate expression of TTP if a co-stimulatory stress signal is provided. IFNinduced expression of TTP depends on the IFN-activated transcription factor STAT1, and the co-stimulatory stress signal requires p38 MAPK. Within the TTP promoter we have identified a functional gamma interferon-activated sequence that recruits STAT1.
Introduction
Interferons (IFNs) are cytokines that were originally described as polypeptides causing activation of antiviral responses 1 . Over the years it became clear that interferons play a major role in immune responses to essentially all infections 2, 3 . IFNs exert their biological effects by regulating gene transcription. Type II IFN (IFN-) induces phosphorylation of the transcription factor STAT1 at Tyr701 that causes STAT1:1 dimer formation, nuclear translocation and DNA binding 4, 5 . Type I IFNs (e.g. IFN-and IFN-) induce tyrosine phosphorylation of STAT1 and STAT2 causing the formation of STAT1:2 heterodimers and STAT1:1 homodimers 4, 5 . STAT1:2 heterodimers acquire their DNA binding ability by associating with the transcription factor IRF9 to form the transcription complex ISGF3. ISGF3 binds to ISRE elements, whereas STAT1 dimers target GAS elements in the promoters of interferon-regulated genes. For full biological activity the transactivation domain of STAT1 requires phosphorylation at Ser727 6, 7 . IFNs cause phosphorylation of both Tyr701 and Ser727 residues. p38 MAPK (p38 MAPK) induces Ser727 phosphorylation only, but can enhance STAT1-driven transcription independently of Ser727 phosphorylation [8] [9] [10] [11] . Thus, STAT1 function and IFN-stimulated gene expression are modulated by p38 MAPK, one of the key inflammation-activated serine kinases. In fact, many inflammation-related genes require both IFNs and p38 MAPK for their maximal stimulation 3, 12 .
One of the major proinflammatory mediators is tumor necrosis factor alpha (TNF ). An acute overproduction or chronically high levels of TNF cause pathological conditions such as septic shock or inflammatory arthritis, respectively 13, 14 . The immune system has developed several mechanisms to limit the production of this potentially harmful For personal use only. on January 15, 2018 . by guest www.bloodjournal.org From cytokine. Regulation of mRNA stability plays a major role in preventing overproduction of TNF 15 . The 3´end of TNF mRNA contains AU-rich elements (AREs) that are recognized by a group of ARE-binding proteins regulating mRNA stability [16] [17] [18] . Gene targeting experiments provided evidence that tristetraprolin (TTP) is an antiinflammatory gene that suppresses TNF production by stimulating ARE-mediated TNF mRNA decay 19, 20 . Mice deficient in TTP display elevated TNF serum levels resulting in cachexia and inflammatory polyarthritis. TTP is an immediate-early gene induced by inflammatory stimuli like LPS or TNF , with p38 MAPK playing a key role herein 20, 21 . TTP is also induced by IL-4 and TGF through the activation of the transcription factors STAT6 and SMAD3/SMAD4, respectively 22, 23 . TTP regulates stability of mRNAs other than TNF as well, most notably GM-CSF and TTP itself [24] [25] [26] .The biological activity of TTP is regulated by phosphorylation that plays a role in association of TTP with stress granules, the sites of ARE-mediated mRNA decay 21, [27] [28] [29] .
Previously we have shown that transcription of IRF1, a known IFN target gene, is synergistically induced by IFN and p38 MAPK signaling 10 . In a DNA microarray-based screen we have identified TTP as another gene synergistically induced by IFN-and p38 MAPK. We have characterized a functional GAS element in the TTP promoter that is capable of recruiting STAT1. Our study shows that STAT1 is required for maximal expression of TTP after stimulation of macrophages with LPS. LPS-induced expression of TTP can be further strongly enhanced by co-treatment with IFNs. We further demonstrate that IFN-induced TTP expression restrains the induction of the proinflammatory genes TNF , IL-6, CCL2 and CCL3. Thus, by amplifying TTP 
Materials and Methods

Cell culture
p38I(-/-), p38I(+/+), STAT1(-/-) and STAT1(+/+) immortalized fibroblasts have been described recently 10, 30 . Cells were maintained in DMEM supplemented with 10% FCS.
Primary bone marrow macrophages (BMM) were obtained from 8 -12 weeks old mice and cultivated in L cell-derived CSF-1 as reported previously 31 . STAT1-deficient mice 32 were of mixed 129Sv/CD1, and TTP-deficient 19 as well as IFN-L-deficient mice of C57Bl/6 background. Mice were housed under specific pathogen-free conditions. Mouse macrophage line Bac 1.2F5 was grown as described 33 . Mouse macrophage line J774 was grown in DMEM supplemented with 10% FCS.
Cytokines, reagents and antibodies
Recombinant IFN-M (kindly provided by G. Adolf, Boehringer Ingelheim, Austria) was used at 10 ng/ml for times indicated. Recombinant IFN-L was purchased from Calbiochem (Darmstadt, D) and used at 200 U/ml. LPS from Salmonella Minnesota (Alexis, Lausen, CH) and anisomycin (Sigma, Vienna, Austria) were used at 100 ng/ml for the times specified. Antiserum to STAT1 C-terminus (S1) has been described (Kovarik, 1998) . Antibodies to Tyr701-phosphorylated STAT1 (pY701-S1) and phosphorylated p38 (pp38) were from Cell Signaling (NEB, Frankfurt/Main, Germany).
Monoclonal antibodies to STAT1 N-terminus (S1-N) and to extracellular signal regulated 
Transient transfection and luciferase assays
pGL2 Luciferase reporter vectors, pGL2basic and pGL2promoter, were from Promega (Mannheim, Germany). 2 kb (-2025 to +25) and 194 bp (-2085 to -1891) fragments of the mouse TTP promoter were amplified by PCR from genomic mouse fibroblast DNA, cloned into pGL2basic and pGL2promoter to obtain the plasmids pGL-TTP and pGL-TTP-GAS, respectively. Both constructs were verified by sequencing. The 2kb fragment was amplified using the forward primer 5'-ATCTCGAGGTTACAAGAGAAGGAACCCAA-3' and reverse primer 5'ATAAGCTTTGTCGGTTCGCAGAAGTCAGG-3', and inserted into pGL2basic using XhoI and HindIII restriction sites. The 194 bp fragment was amplified using 5'-ACGACGCGTCGGCCCCTCCTTCCCTTCTTTTCC-3' as forward and 5'-CCCTCGAGGGCATAGGCTGCTGTGGCACGG-3' as reverse primer and cloned into the pGL2promoter plasmid using MluI and XhoI to obtain the plasmid pGL2-TTP-GAS.
Transfections were performed using ExGen500 (Fermentas, St. Leon-Rot, Germany).
pGL2-TTP together with pEF-Zeo 30 was co-transfected into p38 (+/+) cells and a bulk culture was established by a 2-week-long selection with 100 Qg/ml zeocin. pGL-TTP-GAS was transiently transfected into STAT1(+/+) and STAT1(-/-) fibroblasts.
For personal use only. on January 15, 2018. by guest www.bloodjournal.org From Transfection efficiency was controlled using ecdysone inducible system (Invitrogen, Lofer, Austria) as previously described 10 .
Luciferase assays were performed in triplicates, according to standard protocols 34 .
ELISAs
For Enzyme-linked immunosorbent assays (ELISAs), BMMs were seeded the day before use at 5 x 10 4 cells per well in 96-well tissue plates. Supernatants were diluted 1:7 in DMEM, and TNFI and IL-6 were assayed in triplicates using Quantikine kits (R&D, Minneapolis, MN).
Western blot and electrophoretic mobility-shift assay (EMSA)
Western blot analysis was performed using whole cell extracts from 2 x 10 6 BMM as previously described 35 . For EMSA, whole cell extracts from 5 x 10 6 Bac 1.2F5 cells were prepared and processed as described 35 . Oligonucleotides used in EMSA: TTP-
GAS
(fwd 5'-CTAGCGGCTTCCAGGAAGCCCG-3', rev 5'-GCCGAAGGTCCTTCGGGCGATC-3') and mutTTP-GAS (fwd 5'-CTAGCGGCTTAAAGGAAGCCCG-3', rev 5'-GCCGAATTTCCTTCGGGCGATC-3').
Quantitation of gene expression by quantitative RT-PCR (qRT-PCR)
Total RNA was isolated using nucleo-spin reagent kit (Clontech). Reverse transcription was performed with the Mu-MLV reverse transcriptase (Fermentas). The following primers were used: for HPRT, the housekeeping gene used for normalisation, were . Analysis of the immunoprecipitated DNA was performed by PCR using primers for the TTP promoter (fwd 5'-ATTGGCTGGCTCAGGGATTTGT-3' and rev 5'-CATAGGCTGCTGTGGCACGG-3').
Nuclear run-on
Nuclear run-on reactions were performed as previously described 37 , with some modifications. Briefly, nuclei were prepared from 8 x 10 6 cells by lysis in hypotonic buffer (10 mM HEPES, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.1% Nonident P-40, 1mM DTT), followed by 6 up and down strokes through a 25 G syringe. Nuclei were isolated by centrifugation (500g), and pellets were resuspended in 100 Ql of glycerol buffer (40% 
Statistical analysis
Data from independent experiments were analyzed using univariate linear regression models and the SPSS program (SPSS, Chicago, IL). For qRT-PCR, untransformed normalized Ct-values, for ELISA, pg/ml were used as raw data. Residuals were plotted, visually inspected, and tested for normality. Design matrices were specified such that the coefficients for the relevant comparisons could be calculated, e.g., between the baseline and induced states and between genotypes. Only the significance levels are reported.
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Results
Interferons require STAT1 and activation of p38 MAPK to induce transcription of TTP STAT1 is activated by IFNs independently of p38 MAPK, that is however able to further enhance STAT1 transcriptional activity 10, 11 . We employed mouse 16K cDNA microarrays to find genes that are strongly activated only if both STAT1 (by IFN-) and p38 MAPK (by anisomycin) are stimulated (data not shown). We identified tristetraprolin, TTP, to be regulated in the desired way and validated the DNA-microarray data by quantitative RT-PCR (qRT-PCR). Immortalized p38 (-/-) MEFs and control MEFs were stimulated with IFN-, anisomycin or both. p38 (-/-) cells are lacking p38 isoform, the most abundant of the known p38 , , , and isoforms. p38 (-/-) cells display a very weak p38 activity that is due to the low expression of the remaining p38 genes 10 . The p38 (-/-) cells have therefore been widely used to evaluate the contribution of p38 MAPK to various biological phenomena (e.g. These data demonstrate that IFNs strongly induce TTP expression if a p38 MAPK stimulus is provided simultaneously.
TTP promoter contains a functional GAS element that binds STAT1
TTP contains within the 3´UTR an ARE that regulates the mRNA stability 25, 26 . The low induction of TTP mRNA levels by IFNs alone (without the p38 MAPK stimulus) could be explained by constitutive decay of TTP mRNA due to the ARE. The destabilizing activity of AREs is known to be released by activation of p38 MAPK 18, 41 . Thus, the requirement of p38 MAPK in IFN-induced TTP expression might reflect the need to stabilize the newly synthesized mRNA by p38 rather than a p38-derived input in the transcription machinery. To address this issue, we cloned a 2kb fragment of the TTP promoter into the pGL2basic vector to obtain the plasmid pGL-TTP. The cloned fragment spans the region from bp -2025 to +25 and contains a GAS element (i.e. STAT1 Activation of transcription by STAT1 is mediated by GAS elements, 13 bp long stretches of DNA that recruit STAT1 dimers (Figure 2A ) 42 . We have identified a potential GAS at the position -1976 to -1964 in the mouse TTP promoter (Figure 2A ). The TTP-GAS was investigated for its STAT1 binding activity using EMSA experiments with TTP-GAS and a mutated version (mutTTP-GAS) that contained two point mutations within the GAS core sequence (Figure 2A ). We detected STAT1 binding to the TTP-GAS that was abolished by the point mutations ( Figure 2D ). The presence of STAT1 was confirmed by super-shift using a STAT1 antibody. To investigate whether the TTP-GAS is a functional transcription-enhancing element, the TTP-GAS together with its flanking sequences (-2085 to -1891) was cloned into the pGLpromoter vector, and the resulting plasmid pGL-TTP-GAS was transfected into STAT1-WT cells and STAT1(-/-) cells. Luciferase was induced in IFN--stimulated STAT1-WT cells but not in STAT1(-/-) cells ( Figure 2E ). The luciferase induction was reproducibly 2 -3-fold which is consistent with reported constructs containing one GAS element only 43 . Thus, we identified a functional GAS within the promoter of the mouse TTP gene. Inspection of the human TTP gene uncovered the presence of a GAS at a similar position implicating a conserved transcriptional regulation of both human and mouse TTP.
To strengthen the evidence for STAT1 binding to the TTP promoter, chromatin immunoprecipitations (ChIP) were performed. Chromatin was precipitated from IFN--treated or untreated MEFs using a STAT1 antibody. DNA was recovered from the immunocomplexes and a fragment of the TTP promoter comprising the TTP-GAS was PCR amplified. The promoter fragment was amplified from the IFN--treated sample proving IFN--inducible binding of STAT1 to the TTP promoter ( Figure 2F ).
These data establish STAT1 to bind to the TTP promoter thereby facilitating transcription of the TTP gene.
Maximal LPS-induced TTP expression requires STAT1
To find out whether the increase of TTP mRNA by the synergy of IFN and p38 MAPK pathways causes an equivalent rise in protein levels, Western blotting together with qRT-PCR analyses were performed. To activate p38 MAPK LPS was applied instead of
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anisomycin since LPS is a physiological p38 agonist known to strongly induce TTP 20, 21, 27 . Primary bone marrow-derived macrophages (BMM) were stimulated for 1h (for qRT-PCR experiments, Figure 3A ) or 3h (for Western blot analysis, Figure 3B [44] [45] [46] [47] . IFN-in turn activates STAT1 and STAT2, and consequently the expression of GAS-and ISRE-containing genes resulting in maximal activation of macrophages. Hence, LPS causes activation of both p38 MAPK and IFN pathways thereby providing a system to examine their influence on gene expression under physiological conditions. We used this system to investigate the biological significance of the synergistic effects of IFNs and p38 MAPK on TTP expression. BMM isolated from WT and STAT1KO mice were treated with LPS for 1 and 4h (in case of qRT-PCR, Figure 3C ), and for 2 and 4h (in case of Western blots, Figure 3D ). The experiments demonstrated that both TTP mRNA and protein are rapidly 
IFN-stimulated TTP expression limits induction of TNF and IL-6 in activated macrophages
We asked whether the increased TTP expression in macrophages treated with both IFNs and LPS compared to single treatments alone might affect the expression of TNF , a known TTP target. BMM from TTPKO and littermate wild type (TTPWT) mice were treated with LPS, IFN-or both, and the TNF mRNA and protein levels were monitored ( Figure 4A and B) . IFN-did not induce TNF mRNA in TTPWT cells whereas it caused a weak but consistent 6-8-fold induction in TTPKO cells, indicating that IFNcan activate TNF expression in the absence of TTP. LPS-induced TNF mRNA levels were approximately 3-fold higher in TTPKO cells than in TTPWT cells, thus in agreement with published data on TTP-mediated destabilization of TNF transcripts 19, 48 . Importantly, TNF mRNA was even more induced in TTPKO macrophages treated with both IFN-and LPS whereas it slightly decreased in double-treated TTPWT macrophages ( Figure 4A ). This effect resulted in 10-fold higher TNF mRNA levels in double-treated TTPKO cells compared to TTPWT cells. Quantification of secreted TNF revealed that during the treatment (2h -4h) with both IFN-and LPS the TNF levels increased by 80% in supernatants of TTPKO but only by 5% in the supernatants of TTPWT macrophages ( Figure 4B ). This continuous production caused 3-fold higher TNF levels after 4h in supernatants of TTPKO compared to control cells. Importantly, although LPS caused higher production of TNF in TTPKO cells compared to TTPWT cells, the total
TNF levels remained below those of double-treated cells and the increase over the time remained low (15% in TTPKO versus no increase in TTPWT cells). IFN-alone did not
For personal use only. on January 15, 2018. by guest www.bloodjournal.org From induce TNF secretion in either cells although it caused a modest increase of TNF mRNA in TTPKO cells. This result is consistent with the inability of IFN-to activate p38 MAPK that is required for translation of TNF mRNA and secretion of the cytokine 17 . The lacking p38 MAPK activation by IFN-alone is shown in Figure 4C . To rule out that an increased IFN signaling in TTPKO cells was responsible for the higher IFN--dependent TNF expression in TTPKO macrophages we analyzed the activation of STAT1. Figure 4D demonstrates that activation of STAT1 by IFN-was not augmented in TTPKO cells. In fact, we observed an approximately 2-fold lower STAT1 activation at very early time points (data not shown).
One of the other major cytokines produced by activated macrophages is IL-6. To investigate whether TTP plays a similar role in IL-6 expression as in TNF expression, we performed ELISA to detect secreted IL-6 in TTPKO and control BMM stimulated with IFN-, LPS or both ( Figure 4E ). Similar to TNF , the production of IL-6 was strongly enhanced by double treatment (LPS and IFN-) in TTPKO cells and raised by 60% between 4h and 6h of treatment whereas in TTPWT cells IL-6 was 2-fold lower after 4h and increased only by 5% after 6h. Importantly, IFN-alone did not induce IL-6 in either cells and LPS caused only a weak IL-6 expression that was 20% higher in TTPKO cells.
These results demonstrate that IFNs have the potential to strongly augment LPS-induced TNF and IL-6 expression, and this effect is counter-balanced by the simultaneous induction of TTP.
IFNs exhibit a TTP-dependent suppressive effect on expression of Ccl2 and Ccl3
We reasoned that the IFN-induced TTP protein might act on other proinflammatory molecules such as chemokines. According to the ARE database human Ccl3 contains AREs in its 3´UTRs 49 . Similar sequences are found in the mouse chemokine genes Ccl2 In this study we have characterized a GAS element within the TTP promoter that is conserved in mice and men. The TTP-GAS binds STAT1, yet STAT1 needs, in addition to IFNs, a p38-derived stimulus to activate TTP transcription. This finding is consistent with reports on the role of p38 MAPK in promoting STAT1-driven transcription 10, 11 .
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While the molecular mechanism of the synergy is currently not known, our findings indicate that the number of IFN-stimulated genes (currently >300, 55 ) will grow considerably if the IFN stimulus is supported by a p38 MAPK agonist.
In conclusion, we establish IFNs and the IFN-activated transcription factor STAT1 to play an important role in the transcription of TTP, a major ARE-directed TNF mRNA destabilizing factor. The IFN signal must be accompanied by a p38 MAPK stimulus for 
